-
W.
Long,
M.
Pray-Grant,
J.
Tsai,
G.
Perdew
(1998)
Protein kinase C activity is required for aryl hydrocarbon receptor pathway-mediated signal transduction.
Molecular pharmacology, 53 4
-
Yanan
Tian,
S.
Ke,
M.
Denison,
A.
Rabson,
M.
Gallo
(1999)
Ah Receptor and NF-κB Interactions, a Potential Mechanism for Dioxin Toxicity*
The Journal of Biological Chemistry, 274
-
Y.
Umayahara,
Y.
Kajimoto,
Y.
Fujitani,
S.
Gorogawa,
T.
Yasuda,
A.
Kuroda,
K.
Ohtoshi,
S.
Yoshida,
D.
Kawamori,
Y.
Yamasaki,
M.
Hori
(2002)
Protein Kinase C-dependent, CCAAT/Enhancer-binding Protein β-mediated Expression of Insulin-like Growth Factor I Gene*
The Journal of Biological Chemistry, 277
-
S.
Ke,
A.
Rabson,
J.
Germino,
M.
Gallo,
Yanan
Tian
(2001)
Mechanism of Suppression of Cytochrome P-450 1A1 Expression by Tumor Necrosis Factor-α and Lipopolysaccharide*
The Journal of Biological Chemistry, 276
-
P.
Pocar,
Bernd
Fischer,
T.
Klonisch,
S.
Hombach-Klonisch
(2005)
Molecular interactions of the aryl hydrocarbon receptor and its biological and toxicological relevance for reproduction.
Reproduction, 129 4
-
M.
Watson,
T.
Devereux,
D.
Malarkey,
M.
Anderson,
R.
Maronpot
(1995)
H-ras oncogene mutation spectra in B6C3F1 and C57BL/6 mouse liver tumors provide evidence for TCDD promotion of spontaneous and vinyl carbamate-initiated liver cells.
Carcinogenesis, 16 8
-
C.
Klinge,
K.
Kaur,
H.
Swanson
(2000)
The aryl hydrocarbon receptor interacts with estrogen receptor alpha and orphan receptors COUP-TFI and ERRalpha1.
Archives of biochemistry and biophysics, 373 1
-
M.
Göransson,
E.
Elias,
A.
Ståhlberg,
Anita
Olofsson,
C.
Andersson,
P.
Åman
(2005)
Myxoid liposarcoma FUS‐DDIT3 fusion oncogene induces C/EBP β‐mediated interleukin 6 expression
International Journal of Cancer, 115
-
J.
Marlowe,
A.
Puga
(2005)
Aryl hydrocarbon receptor, cell cycle regulation, toxicity, and tumorigenesis
Journal of Cellular Biochemistry, 96
-
M.
Tjiong,
N.
Vange,
F.
Kate,
S.
Tjong-A-Hung,
J.
Schegget,
M.
Burger,
T.
Out
(1999)
Increased IL-6 and IL-8 levels in cervicovaginal secretions of patients with cervical cancer.
Gynecologic oncology, 73 2
-
A.
Sasser,
N.
Sullivan,
A.
Studebaker,
L.
Hendey,
A.
Axel,
B.
Hall
(2007)
Interleukin‐6 is a potent growth factor for ER‐α‐positive human breast cancer
The FASEB Journal, 21
-
A.
Sasser,
B.
Mundy,
Kristen
Smith,
A.
Studebaker,
A.
Axel,
Amanda
Haidet,
S.
Fernandez,
B.
Hall
(2007)
Human bone marrow stromal cells enhance breast cancer cell growth rates in a cell line-dependent manner when evaluated in 3D tumor environments.
Cancer letters, 254 2
-
T.
Beischlag,
G.
Perdew
(2005)
ERα-AHR-ARNT Protein-Protein Interactions Mediate Estradiol-dependent Transrepression of Dioxin-inducible Gene Transcription*
Journal of Biological Chemistry, 280
-
A.
Poland,
D.
Palen,
E.
Glover
(1982)
Tumour promotion by TCDD in skin of HRS/J hairless mice
Nature, 300
-
O.
Moennikes,
Sandra
Loeppen,
A.
Buchmann,
Patrik
Andersson,
C.
Ittrich,
L.
Poellinger,
M.
Schwarz
(2004)
A Constitutively Active Dioxin/Aryl Hydrocarbon Receptor Promotes Hepatocarcinogenesis in Mice
Cancer Research, 64
-
Yanan
Tian,
A.
Rabson,
M.
Gallo
(2002)
Ah receptor and NF-κB interactions: mechanisms and physiological implications
Chemico-Biological Interactions, 141
-
J.
Krueger,
J.
Krane,
D.
Carter,
A.
Gottlieb
(1990)
Role of growth factors, cytokines, and their receptors in the pathogenesis of psoriasis.
The Journal of investigative dermatology, 94 6 Suppl
-
T.
Sugawara,
R.
Gallucci,
R.
Gallucci,
P.
Simeonova,
M.
Luster
(2001)
Regulation and role of interleukin 6 in wounded human epithelial keratinocytes.
Cytokine, 15 6
-
A.
Karczewska,
S.
Nawrocki,
D.
Brȩborowicz,
V.
Filas,
A.
Mackiewicz
(2000)
Expression of interleukin‐6, interleukin‐6 receptor, and glycoprotein 130 correlates with good prognoses for patients with breast carcinoma
Cancer, 88
-
D.
Nebert,
Joseph
Robinson,
A.
Niwa,
Kenji
Kumari,
A.
Poland
(1975)
Genetic expression of aryl hydrocarbon hydroxylase activity in the mouse
Journal of Cellular Physiology, 85
-
Kristine
Burbach,
A.
Poland,
C.
Bradfield
(1992)
Cloning of the Ah-receptor cDNA reveals a distinctive ligand-activated transcription factor.
Proceedings of the National Academy of Sciences of the United States of America, 89 17
-
Franca
Armenante,
Marcello
Merola,
A.
Furia,
Michael
Tovey,
Marta
Palmieri
(1999)
Interleukin-6 repression is associated with a distinctive chromatin structure of the gene.
Nucleic acids research, 27 22
-
Soo
Lee,
J.
Chun,
N.
Nadiminty,
W.
Lou,
A.
Gao
(2007)
Interleukin‐6 undergoes transition from growth inhibitor associated with neuroendocrine differentiation to stimulator accompanied by androgen receptor activation during LNCaP prostate cancer cell progression
The Prostate, 67
-
H.
Jeong
(2001)
Cytokine-mediated suppression of cytochrome P450 1A1 in Hepa-1c1c7 cells by pokeweed mitogen.
Toxicology letters, 119 2
-
I.
Cavarretta,
H.
Neuwirt,
G.
Untergasser,
P.
Moser,
M.
Zaki,
H.
Steiner,
H.
Rumpold,
D.
Fuchs,
A.
Hobisch,
J.
Nemeth,
Z.
Culig
(2007)
The antiapoptotic effect of IL-6 autocrine loop in a cellular model of advanced prostate cancer is mediated by Mcl-1
Oncogene, 26
-
H.
Knüpfer,
R.
Preiss
(2007)
Significance of interleukin-6 (IL-6) in breast cancer (review)
Breast Cancer Research and Treatment, 102
-
E.
Ludolphy
(1950)
[Cancer cells].
Medizinische Monatsschrift, 4 11
-
K.
Nettles,
G.
Gil,
J.
Nowak,
R.
Métivier,
Vandana
Sharma,
G.
Greene
(2008)
CBP Is a dosage-dependent regulator of nuclear factor-kappaB suppression by the estrogen receptor.
Molecular endocrinology, 22 2
-
Dietrich
Conze,
L.
Weiss,
Patricia
Regen,
Alok
Bhushan,
Donald
Weaver,
Peter
Johnson,
Mercedes
Rincon
(2001)
Autocrine production of interleukin 6 causes multidrug resistance in breast cancer cells.
Cancer research, 61 24
-
T.
Hama,
M.
Miyamoto,
H.
Tsukui,
C.
Nishio,
H.
Hatanaka
(1989)
Interleukin-6 as a neurotrophic factor for promoting the survival of cultured basal forebrain cholinergic neurons from postnatal rats
Neuroscience Letters, 104
-
N.
Gharavi,
A.
El-Kadi
(2005)
Down-regulation of aryl hydrocarbon receptor-regulated genes by tumor necrosis factor-alpha and lipopolysaccharide in murine hepatoma Hepa 1c1c7 cells.
Journal of pharmaceutical sciences, 94 3
-
P.
Angel,
M.
Imagawa,
R.
Chiu,
B.
Stein,
R.
Imbra,
H.
Rahmsdorf,
C.
Jonat,
P.
Herrlich,
M.
Karin
(1987)
Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor
Cell, 49
-
Yue‐Hwa
Chen,
R.
Tukey
(1996)
Protein Kinase C Modulates Regulation of the CYP1A1 Gene by the Aryl Hydrocarbon Receptor*
The Journal of Biological Chemistry, 271
-
Iris
Camacho,
Narendra
Singh,
V.
Hegde,
M.
Nagarkatti,
P.
Nagarkatti
(2005)
Treatment of Mice with 2,3,7,8-Tetrachlorodibenzo-p-Dioxin Leads to Aryl Hydrocarbon Receptor-Dependent Nuclear Translocation of NF-κB and Expression of Fas Ligand in Thymic Stromal Cells and Consequent Apoptosis in T Cells1
The Journal of Immunology, 175
-
K.
Bock,
C.
Koehle
(2005)
Ah receptor- and TCDD-mediated liver tumor promotion: clonal selection and expansion of cells evading growth arrest and apoptosis.
Biochemical pharmacology, 69 10
-
J.
Reiners,
A.
Schöller,
P.
Bischer,
A.
Cantu,
A.
Pavone
(1993)
Suppression of cytochrome P450 Cyp1a-1 induction in murine hepatoma 1c1c7 cells by 12-O-tetradecanoylphorbol-13-acetate and inhibitors of protein kinase C.
Archives of biochemistry and biophysics, 301 2
-
J.
Reiners,
A.
Cantu,
A.
Schöller
(1992)
Phorbol ester-mediated suppression of cytochrome P450 Cyp1a-1 induction in murine skin: involvement of protein kinase C.
Biochemical and biophysical research communications, 186 2
-
B.
Davis,
Elizabeth
McCurdy,
B.
Miller,
G.
Lucier,
A.
Tritscher
(2000)
Ovarian tumors in rats induced by chronic 2,3,7,8-tetrachlorodibenzo-p-dioxin treatment.
Cancer research, 60 19
-
Wes
Lee,
P.
Mitchell,
R.
Tjian
(1987)
Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements
Cell, 49
-
Weihua
Xiao,
D.
Hodge,
Lihua
Wang,
Xiaoyi
Yang,
Xiaohu
Zhang,
W.
Farrar
(2004)
Co‐operative functions between nuclear factors NFκB and CCAT/enhancer‐binding protein‐β (C/EBP‐β) regulate the IL‐6 promoter in autocrine human prostate cancer cells
The Prostate, 61
-
(2007)
Interleukin-6 and its receptor in cancer: implications for translational therapeutics
-
M.
Spiotto,
T.
Chung
(2000)
STAT3 mediates IL‐6‐induced neuroendocrine differentiation in prostate cancer cells
The Prostate, 42
-
Access the most recent version of this article at: Material Supplementary
-
T.
Beischlag,
Robert
Taylor,
D.
Rose,
D.
Yoon,
Yumay
Chen,
Wen-Hwa
Lee,
M.
Rosenfeld,
O.
Hankinson
(2004)
Recruitment of Thyroid Hormone Receptor/Retinoblastoma-interacting Protein 230 by the Aryl Hydrocarbon Receptor Nuclear Translocator Is Required for the Transcriptional Response to Both Dioxin and Hypoxia*
Journal of Biological Chemistry, 279
-
B.
Stein,
M
Yang
(1995)
Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C/EBP beta
Molecular and Cellular Biology, 15
-
(2008)
American Association for Cancer cancerres.aacrjournals.org Downloaded from
-
L.
Faggioli,
C.
Costanzo,
M.
Merola,
E.
Bianchini,
A.
Furia,
A.
Carsana,
M.
Palmieri
(1996)
Nuclear Factor k B (NF‐k B), Nuclear Factor Interleukin‐6 (NFIL‐6 or C/EBPβ) and Nuclear Factor Interleukin‐6β (NFIL6‐β or C/EBPδ) are Not Sufficient to Activate the Endogenous Interleukin‐6 Gene in the Human Breast Carcinoma Cell Line MCF‐7
FEBS Journal, 239
-
B.
Jensen,
R.
Leeman,
J.
Schlezinger,
D.
Sherr
(2003)
Aryl hydrocarbon receptor (AhR) agonists suppress interleukin-6 expression by bone marrow stromal cells: an immunotoxicology study
Environmental Health, 2
-
H.
Takanol,
K.
Harigaya,
G.
Ishii,
Y.
Sugaya,
S.
Soeta,
T.
Nunoyamal,
H.
Shirasawa,
K.
Shimizu,
H.
Tokita,
B.
Simizu,
A.
Mikata,
S.
Sekiya
(2005)
Interleukin-6 (IL-6) production in carcinoma of the cervix
Archives of Gynecology and Obstetrics, 258
-
M.
Baccam,
S.
Woo,
C.
Vinson,
G.
Bishop
(2003)
CD40-Mediated Transcriptional Regulation of the IL-6 Gene in B Lymphocytes: Involvement of NF-κB, AP-1, and C/EBP1
The Journal of Immunology, 170
-
J.
Molitor,
W.
Walker,
S.
Doerre,
D.
Ballard,
W.
Greene
(1990)
NF-kappa B: a family of inducible and differentially expressed enhancer-binding proteins in human T cells.
Proceedings of the National Academy of Sciences of the United States of America, 87 24
-
F.
Basolo,
P.
Conaldi,
L.
Fiore,
S.
Calvo,
A.
Toniolo
(1993)
Normal breast epithelial cells produce interleukins 6 and 8 together with tumor‐necrosis factor: Defective il6 expression in mammary carcinoma
International Journal of Cancer, 55
-
E.
Tartour,
A.
Gey,
X.
Sastre-Garau,
C.
Pannetier,
V.
Mosseri,
P.
Kourilsky,
W.
Fridman
(1994)
Analysis of interleukin 6 gene expression in cervical neoplasia using a quantitative polymerase chain reaction assay: evidence for enhanced interleukin 6 gene expression in invasive carcinoma.
Cancer research, 54 23